Tokyo, June 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058262) titled 'The specified drug use study of tenapanor tablets,"study on the long-term use in hemodialysis patients"' on June 25.
Study Type:
Observational
Primary Sponsor:
Institute - Kyowa Kirin Co.,Ltd.
Condition:
Condition - Hypophosphatemia during hemodialysis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To assess the safety and efficacy of long-term use of tenapanor tablets under real-world conditions in patients with hyperphosphatemia undergoing hemodialysis
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not appli...